Please assess the completion status of the following clinical trial:

Trial Title: Corticosteroid Treatment for Community-Acquired Pneumonia - The STEP Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Patients 18 years of age or older admitted for hospitalization from the community or a nursing home with CAP.~2. CAP will be defined by a new infiltrate on chest radiograph and the presence of one or several of the following acute respiratory signs or symptoms:~   * cough~  * sputum production~  * dyspnea~  * core body temperature \>38.0° C~  * auscultatory findings of abnormal breath sounds and rales~  * leukocyte count \>10 or \<4 x 109 cells L-1 (1)~Exclusion Criteria:~1. Patients or family members unable to give written informed consent, e.g. with severe dementia.~2. Patients with active intravenous drug use.~3. Severe immunosuppression (e.g. patients infected with human immunodeficiency virus infection and a CD4 count below 350 x 109/L, patients on immunosuppressive therapy after solid organ transplantation and neutropenic patients with neutrophil count \< 500 x 109/L and patients under chemotherapy with neutrophils 500-1000 x 109/L with an expected decrease to values \< 500 x 109/L); patients with cystic fibrosis as well as patients with active tuberculosis.~4. Patients with acute burn injury~5. Patients with acute gastrointestinal bleeding within 3 months of the current hospitalization~6. Patients with an acute concomitant condition requiring more than 0.5mg/kg/d prednisone equivalent~7. Pregnancy or breast feeding~8. Patients with known adrenal insufficiency

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Prednisone (Type: ACTIVE_COMPARATOR): Drug
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).